Fig. 5: The TTFT of CLL patients with and without MYD88 mutations.

a Patients with WT MYD88 vs. patients with mutated MYD88. b Patients with L265P mutation vs. patients with non-L265P mutations. c Only patients with mutated IGHV were included for TTFT analysis.